Qube Research & Technologies LTD Alkermes Plc. Transaction History

Qube Research & Technologies LTD

$82.3 Billion
Q1 2025

A detailed history of Qube Research & Technologies LTD transactions in Alkermes Plc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 156,476 shares of ALKS stock, worth $4.87 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

156,476

Previous 186,885 16.27%

Holding current value

$4.87 Million

Previous $5.37 Million 3.87%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$28.08 - $36.0 $853,884 - $1.09 Million	-30,409 Reduced 16.27%	156,476 $5.17 Million
Q4 2024 Feb 14, 2025	BUY	$25.7 - $31.46 $4.8 Million - $5.88 Million	186,885 New	186,885 $5.37 Million
Q2 2024 Aug 14, 2024	BUY	$23.21 - $27.24 $3.96 Million - $4.64 Million	170,454 Added 227.64%	245,334 $5.91 Million
Q1 2024 May 14, 2024	BUY	$26.4 - $32.56 $442,569 - $545,835	16,764 Added 28.85%	74,880 $2.03 Million
Q4 2023 Feb 13, 2024	SELL	$23.37 - $28.68 $1.46 Million - $1.8 Million	-62,662 Reduced 51.88%	58,116 $1.61 Million
Q3 2023 Nov 13, 2023	BUY	$27.17 - $31.97 $3.08 Million - $3.63 Million	113,511 Added 1562.01%	120,778 $3.38 Million
Q2 2023 Aug 14, 2023	BUY	$28.34 - $33.63 $205,946 - $244,389	7,267 New	7,267 $227,000
Q4 2022 Feb 14, 2023	BUY	$21.94 - $26.24 $150,201 - $179,639	6,846 Added 28.72%	30,680 $801,000
Q3 2022 Nov 14, 2022	SELL	$22.0 - $31.87 $2.66 Million - $3.86 Million	-120,965 Reduced 83.54%	23,834 $532,000
Q2 2022 Aug 15, 2022	BUY	$26.4 - $30.54 $2.88 Million - $3.33 Million	109,119 Added 305.83%	144,799 $4.31 Million
Q1 2022 May 09, 2022	BUY	$23.07 - $27.99 $583,117 - $707,475	25,276 Added 242.95%	35,680 $939,000
Q4 2021 Feb 10, 2022	BUY	$21.47 - $32.08 $223,373 - $333,760	10,404 New	10,404 $242,000
Q4 2021 Feb 01, 2022	SELL	$21.47 - $32.08 $285,593 - $426,728	-13,302 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$23.37 - $32.13 $310,867 - $427,393	13,302 New	13,302 $410,000
Q2 2021 Aug 13, 2021	SELL	$18.78 - $25.15 $1.72 Million - $2.3 Million	-91,394 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$18.21 - $23.2 $1.12 Million - $1.42 Million	-61,290 Reduced 40.14%	91,394 $1.71 Million
Q4 2020 Feb 16, 2021	BUY	$15.39 - $22.1 $2.35 Million - $3.37 Million	152,684 New	152,684 $3.05 Million
Q2 2020 Aug 14, 2020	SELL	$13.31 - $19.41 $483,139 - $704,563	-36,299 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$13.06 - $21.24 $843,924 - $1.37 Million	-64,619 Reduced 64.03%	36,299 $523,000
Q4 2019 Feb 13, 2020	BUY	$17.29 - $21.74 $1.74 Million - $2.19 Million	100,918 New	100,918 $2.06 Million

Others Institutions Holding ALKS

# of Institutions

410

Shares Held

177M

Call Options Held

229K

Put Options Held

436K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $5.11B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Alkermes Plc. Transaction History